SCPX:NYE-Scorpius Holdings Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.1586

Change

0.00 (-1.06)%

Market Cap

N/A

Volume

0.20M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-18 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
NVO Novo Nordisk A/S

+0.90 (+0.70%)

USD 562.30B
BHVN Biohaven Pharmaceutical Holdin..

+1.38 (+3.56%)

USD 3.42B
HTD John Hancock Tax Advantaged Di..

+0.10 (+0.51%)

USD 2.41B
DNA Ginkgo Bioworks Holdings

-0.05 (-5.50%)

USD 2.17B
RCUS Arcus Biosciences Inc

+0.27 (+1.77%)

USD 1.41B
NUVB Nuvation Bio Inc

+0.21 (+7.02%)

USD 0.64B
ADCT ADC Therapeutics SA

+0.30 (+6.80%)

USD 0.37B
PGP PIMCO Global StocksPLUS & Inco..

+0.08 (+1.09%)

USD 0.32B
CYBN Cybin Inc

N/A

USD 0.29B
LCTX Lineage Cell Therapeutics Inc

+0.04 (+3.67%)

USD 0.28B

ETFs Containing SCPX

XSDX:LSE Xtrackers ShortDAX Daily .. 3.91 % 0.00 %

+5.60 (+0.00%)

USD 0.21B
DXSN:F Xtrackers - ShortDAX Dail.. 3.91 % 0.00 %

N/A

USD 0.21B
DXSN:XETRA Xtrackers - ShortDAX Dail.. 3.91 % 0.00 %

N/A

USD 0.21B
XSD SPDR® S&P Semiconductor .. 3.25 % 0.35 %

-7.18 (0.00%)

USD 1.46B
XITK SPDR® FactSet Innovative.. 1.47 % 0.45 %

-0.44 (0.00%)

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike